Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 14,668 | 13,491 | 11,872 | 9,056 | 9,607 |
| Cost of Goods | 3,374 | 3,229 | 3,238 | 3,169 | 3,306 |
| Gross Profit | 11,294 | 10,262 | 8,634 | 5,887 | 6,301 |
| Operating Expenses | 18,538 | 17,663 | 19,799 | 22,429 | 20,497 |
| Operating Income | -6,870 | -7,172 | -10,927 | -16,373 | -13,890 |
| Interest Expense | 2,329 | 2,386 | 2,430 | 2,391 | 2,550 |
| Other Income | 60 | -1,391 | 1 | 62 | -3,898 |
| Pre-tax Income | -9,139 | -10,949 | -13,356 | -18,702 | -20,338 |
| Net Income Continuous | -9,139 | -10,949 | -13,356 | -18,702 | -20,338 |
| Net Income | $-9,139 | $-10,949 | $-13,356 | $-18,702 | $-20,338 |
| EPS Basic Total Ops | -1.80 | -2.80 | -3.40 | -4.80 | -6.20 |
| EPS Basic Continuous Ops | -1.74 | -2.75 | -3.40 | -4.81 | -6.22 |
| EPS Diluted Total Ops | -1.80 | -2.80 | -3.40 | -4.80 | -6.20 |
| EPS Diluted Continuous Ops | -1.74 | -2.75 | -3.40 | -4.81 | -6.22 |
| EBITDA(a) | $-4,384 | $-1,979 | $-10,866 | $-13,451 | $-12,218 |